Bora Pharmaceuticals Announces Unveiling of New Multi-Purpose Small Molecule Site
Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Appoints J.D. Mowery As First Division President Of Its
Tanvex BioPharma, Inc. (“Tanvex” or “the Company”, TWSE: 6541), the
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
